A Study to Assess the Long-term Safety, Tolerability, and Efficacy of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis
Clinical trial NCT04009499 · COMPLETED
Trial details
- NCT number
- NCT04009499
- Sponsor
- UCB Biopharma SRL
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-13
- Primary completion
- 2026-05-26
- Enrollment
- 1131
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.